Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
9.97
+0.34 (3.53%)
At close: Jun 6, 2025, 4:00 PM
9.97
0.00 (0.00%)
After-hours: Jun 6, 2025, 7:00 PM EDT

Arcus Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
1,0561,3631,4301,4972,8431,685
Upgrade
Market Cap Growth
-51.57%-4.70%-4.52%-47.33%68.68%263.88%
Upgrade
Enterprise Value
1333516045682,367903
Upgrade
Last Close Price
9.6314.8919.1020.6840.4725.96
Upgrade
PE Ratio
----53.64-
Upgrade
Forward PE
-----12.60
Upgrade
PS Ratio
6.365.2812.2213.377.4221.61
Upgrade
PB Ratio
1.922.813.102.283.383.36
Upgrade
P/TBV Ratio
1.992.813.102.283.383.36
Upgrade
P/FCF Ratio
---3.47-15.61
Upgrade
P/OCF Ratio
---3.42-15.18
Upgrade
EV/Sales Ratio
0.951.365.165.076.1811.58
Upgrade
EV/EBITDA Ratio
----40.82-
Upgrade
EV/EBIT Ratio
----43.84-
Upgrade
EV/FCF Ratio
---1.31-8.36
Upgrade
Debt / Equity Ratio
0.150.330.260.180.140.03
Upgrade
Debt / EBITDA Ratio
----1.80-
Upgrade
Debt / FCF Ratio
---0.28-0.14
Upgrade
Asset Turnover
0.120.230.100.080.320.16
Upgrade
Quick Ratio
5.304.444.355.457.516.00
Upgrade
Current Ratio
5.374.504.525.537.606.05
Upgrade
Return on Equity (ROE)
-63.17%-59.77%-54.87%-35.62%7.89%-36.93%
Upgrade
Return on Assets (ROA)
-22.25%-17.26%-17.42%-11.92%2.85%-15.89%
Upgrade
Return on Capital (ROIC)
-40.37%-31.58%-31.25%-20.16%4.57%-22.75%
Upgrade
Return on Capital Employed (ROCE)
----3.80%-
Upgrade
Earnings Yield
-36.98%-20.77%-21.47%-17.83%1.86%-7.30%
Upgrade
FCF Yield
-28.66%-12.92%-23.08%28.85%-9.92%6.41%
Upgrade
Buyback Yield / Dilution
-20.51%-21.76%-2.78%2.70%-35.04%-25.04%
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q